Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Thromb Thrombolysis ; 57(4): 650-657, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38491266

ABSTRACT

BACKGROUND: The interrelation of cancer with venous thromboembolism is established, yet the specific impact on the incidence and progression of superficial vein thrombosis (SVT) remains unclear. OBJECTIVES: To investigate the association between SVT and malignancies, focusing on risk factors, presentation, course and complications. METHODS: A single-center prospective observational study of patients diagnosed with DVT or SVT referred to a venous thromboembolism clinic between January 2013 and April 2018. RESULTS: Of the 632 patients, 205 presented with SVT at referral, 16.6% having active cancer. Significant associations were found between active cancer and the risk of developing proximal SVT (RR 1.54 [1.18-2.03] p < 0.01), SVT within 3 cm from junction (RR 2.01 [1.13-3.72] p = 0.019), bilateral SVT (RR 8.38 [2.10-33.43] p < 0.01) and SVT affecting multiple veins (RR 2.42 [1.40-4.20] p < 0.01), with a higher risk of persistence (RR 1.51 [1.18-1.95] p < 0.01) and progression (RR 5.75 [2.23-14.79] p < 0.01) at initial assessment. Patients with SVT and no malignancy history demonstrated an elevated risk for new-onset cancer during follow-up (RR 1.43 [1.13-1.18] p = 0.022), especially in cases of proximal or bilateral SVT, initial progression or subsequent DVT or PE. No significant differences were observed in persistence, recurrence or complications during initial evaluation or follow-up across different pharmacological treatments. CONCLUSIONS: Research suggests a probable link between cancer history and the development of SVT. SVT presented more severely in cancer patients. SVT, especially in its more complex forms, could serve as a predictive marker for the future development of cancer. Treatment approaches varied, no significant differences in outcomes were noted.


Subject(s)
Neoplasms , Venous Thromboembolism , Venous Thrombosis , Humans , Venous Thromboembolism/drug therapy , Anticoagulants/therapeutic use , Venous Thrombosis/diagnosis , Risk Factors , Neoplasms/complications
2.
BMJ Case Rep ; 14(4)2021 Apr 13.
Article in English | MEDLINE | ID: mdl-33849879

ABSTRACT

We report COVID-19 multisystemic inflammatory syndrome in an adult patient with an atypical presentation (mild abdominal pain) and a negative (repeated) reverse transcriptase-PCR, in the absence of lung involvement on lung ultrasound. In this case, focused cardiac ultrasound revealed signs of myopericarditis and enabled us to focus on the problem that was putting our patient in a perilous situation, with a quick, non-time-consuming and easy-to-access technique. Serology test was performed and SARS-CoV-2 infection was confirmed more than a week after admission to the coronary unit. As the patient had a general good appearance, the potential implications of missing this diagnosis could have been fatal.


Subject(s)
COVID-19/diagnosis , Myocarditis/diagnostic imaging , Pericarditis/diagnostic imaging , Systemic Inflammatory Response Syndrome/virology , Abdominal Pain , Adult , COVID-19/complications , COVID-19 Serological Testing , Echocardiography , Humans , Lung/diagnostic imaging , Male , Myocarditis/virology , Pericarditis/virology , Systemic Inflammatory Response Syndrome/diagnosis , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...